Contact
Please use this form to send email to PR contact of this press release:
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
TO:
Please use this form to send email to PR contact of this press release:
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
TO: